SCHEMBL18789762

SCHEMBL18789762

O=C1CCc2cc(NC(=O)c3cccc(C(=O)Nc4cnccn4)c3)ccc2N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 1/20 0.51
▸ ALOX15 P16050 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ CASP1 P29466 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ ALDH1A2 O94788 3/20 0.49
▸ ROCK2 O75116 2/20 0.49
▸ ULK1 O75385 2/20 0.47
▸ SIRT2 Q8IXJ6 1/20 0.47
▸ KMT2A Q03164 1/20 0.46
▸ KIF11 P52732 1/20 0.45
▸ CRBN Q96SW2 2/20 0.45
▸ HDAC3 O15379 1/20 0.44
▸ HDAC4 P56524 1/20 0.44
▸ HDAC1 Q13547 1/20 0.44
▸ HDAC2 Q92769 1/20 0.44
▸ HDAC8 Q9BY41 1/20 0.44
▸ HDAC6 Q9UBN7 1/20 0.44
▸ HDAC9 Q9UKV0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25547935 0.88 MAP4K1 (0.45) MAP4K1ALDH1A2ROCK2ULK1KMT2A
SCHEMBL30444662 0.82 CYP3A4 (0.63) ALOX15TSHRCASP1NPSR1HSD17B10
SCHEMBL22284858 0.82 CYP3A4 (0.63) ALOX15TSHRCASP1NPSR1HSD17B10
SCHEMBL25547933 0.81 MAP4K1 (0.47) MAP4K1ALDH1A2ROCK2ULK1KIF11
SCHEMBL9378760 0.80 MAP4K1 (0.60) MAP4K1HSD17B10ALDH1A2ROCK2KIF11
SCHEMBL10365448 0.80 MAP4K1 (0.65) MAP4K1ALDH1A2ROCK2KIF11CRBN
SCHEMBL31680533 0.79 NPC1 (0.56) MAP4K1ALDH1A2ROCK2KMT2AKIF11
SCHEMBL31139953 0.77 MAP4K1 (0.50) MAP4K1ALDH1A2ROCK2ULK1KIF11
SCHEMBL26441313 0.77 MAP4K1 (0.53) MAP4K1ALDH1A2ROCK2KIF11CRBN
SCHEMBL25547937 0.76 MAP4K1 (0.43) MAP4K1ALDH1A2ROCK2ULK1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017070719-A2 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIVERSITY OF TECHNOLOGY (ZA) 2017-04-27 — — WO disclosed
WO-2017070718-A1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIVERSITY OF TECHNOLOGY (ZA) 2017-04-27 — — WO disclosed
Send feedback